Understanding PSMA PET Imaging in Prostate Cancer

Sponsored by Novartis Pharmaceuticals Corporation

Learn about advancements in using PSMA PET imaging for the evaluation of Prostate Cancer

The use of PSMA PET in evaluating Prostate Cancer has increased in recent years. This presentation will review PSMA PET imaging, including the technology, its impact across the spectrum of Prostate Cancer stages, and guideline recommendations for PSMA PET use.

Click here to Download